Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 3 offices
active in Legal Services and IP Consulting

We have observed 44 EP applications Richard Edward Gillard has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11840795

ALUMINA CATALYST SUPPORT

IPC classification:
B01J 21/12
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP11842211

SULFUR TOLERANT ALUMINA CATALYST SUPPORT

IPC classification:
B01J 21/12
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP12718318

A DEVICE FOR DETECTING AN ANALYTE

IPC classification:
G01N 21/17, G01N 29/24, G01N 33/542, G01N 33/543
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11865208

METHOD FOR TREATING PROSTATE CANCER

IPC classification:
A61K 36/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11742587

RHEOLOGY MODIFIER POLYMER

IPC classification:
C08F 283/04, C08F 283/06, C08F 290/06, C08G 69/48, C08L 77/00
Applicant:
Rhodia Operations SAS
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
The patent has been granted
EP11839738

AGRICULTURAL PESTICIDE COMPOSITIONS

IPC classification:
A01N 59/20, A01N 25/02, A01N 25/04, A01N 37/34, A01N 43/653, A01N 47/36, A01N 53/08, A01N 57/20, A01P 3/00, A01P 7/00, A01P 13/00
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12817817

CYSTEINE PRODRUGS

IPC classification:
A61P 25/00, C07D 277/14, A61K 31/426
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12823540

SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS

IPC classification:
C07C 241/00, C07C 243/00, A01N 37/36
Applicant:
University of Utah Research Foundation
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13003519

Novel polymorphic forms of perindopril (L)-arginine and process for the preparation thereof

IPC classification:
A61P 9/12, C07D 209/42, A61K 31/404
Agent:
Alexander Wittkopp, Maiwald Patentanwalts GmbH
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12853818

SINGLE MODE MICROWAVE DEVICE FOR PRODUCING EXFOLIATED GRAPHITE

IPC classification:
B01J 19/12, C01B 31/04
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP12810409

METHOD AND DEVICE FOR MEASURING COAGULATION IN A SAMPLE OF A BLOOD PRODUCT

IPC classification:
B01L 3/00, B82Y 15/00, G01N 15/05, G01N 21/17, G01N 21/82, G01N 25/48, G01N 29/02, G01N 29/24, G01N 33/49, G01N 33/86
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806382

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61P 11/00, A61K 9/00, A61K 9/12, A61K 31/46
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Status:
PATENT GRANTED
EP12805442

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61P 11/00, A61K 9/12, A61K 31/46
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva Global Patent Group
Agent:
David William Cottam, Teva UK Ltd.
Status:
GRANT OF PATENT INTENDED
EP12779275

TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF

IPC classification:
A61P 29/00, A61K 31/192, A61K 47/10, A61K 47/14, A61K 47/18, A61K 47/20, A61K 47/22, A61K 47/38
Agent:
Multiple attorneys, Fish & Richardson PC
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12766194

COMPOSITIONS AND METHODS FOR TREATMENT OF GLAUCOMA

IPC classification:
A61K 9/00, A61K 47/10
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION WITHDRAWN
EP13746990

BLAST TREATMENT METHOD

IPC classification:
B21J 5/06, B30B 5/00, F42B 33/06, F42D 5/04
Applicant:
Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel Ltd)
Agent:
Multiple attorneys, Elkington and Fife LLP
Status:
PATENT GRANTED
EP13726306

AN IMPROVED PROCESS FOR THE PREPARATION OF ALISKIREN

IPC classification:
C07C 231/12, C07C 231/22
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14158985

Amorphous rotigotine transdermal system

IPC classification:
A61K 9/70, A61K 31/381
Agent:
Christopher K. Hamer, Mathys & Squire LLP
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP13718030

AN ASSAY LABEL

IPC classification:
G01N 33/543, G01N 33/548, G01N 33/58
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11772354

EXPANDABLE ELASTOMERIC MATERIAL IN THE PRESENCE OF WATER OR OIL

IPC classification:
C08F 2/32, C08F 220/56, C08L 33/26, C08L 75/14, C08L 83/04, C09K 8/28
Applicant:
Rhodia Operations SAS
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP14809248

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14809570

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13844898

COMBINATION DRUG COMPRISING GEMIGLIPTIN AND METFORMIN, AND METHOD FOR THE PREPARATION THEREOF

IPC classification:
A61K 9/20, A61K 9/24, A61K 31/155
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852301

THIOARYL DERIVATIVES AS GPR120 AGONISTS

IPC classification:
A61P 3/10, C07D 213/80, C07D 241/18, A61K 31/44
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13852767

GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT

IPC classification:
A61P 3/10, C07D 209/22, C07D 409/04, A61K 31/404
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP13859129

AUTOMATIC IN VITRO DIAGNOSTIC APPARATUS INCLUDING INCLINED ROTATING PLATE

IPC classification:
G01N 21/78, G01N 33/52, G01N 33/53, G01N 37/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP15161261

PROPIONIC ACIDS, PROPIONIC ACID ESTERS, AND RELATED COMPOUNDS

IPC classification:
A61P 25/18, C07C 323/57, C07D 211/80, C07D 309/02, A61K 31/195
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP14746632

PPAR AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, A61K 31/47
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14778370

MICRONIZED PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/14
Agent:
Hoffmann Eitle PartmbB
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14764870

COMPLEX PREPARATION INCLUDING VALSARTAN AND ROSUVASTATIN CALCIUM AND MANUFACTURING METHOD THEREFOR

IPC classification:
A61P 3/00, A61P 3/06, A61K 31/41, A61K 31/505
Applicant:
LG Chem Ltd
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP14791773

INTERMEDIATE CONNECTOR

IPC classification:
B29C 45/76
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP12196725

An inhalable medicament comprising tiotropium

IPC classification:
A61P 11/00, A61K 9/00, A61K 9/12, A61K 31/46
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP13151885

Method of protecting teeth against erosion

IPC classification:
A61Q 11/00, A23G 4/06, A23G 4/08, A61K 8/19, A61K 8/21, A61K 8/24, A61K 8/81
Applicant:
The Procter & Gamble Company
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
Uta Susanne Joos, Braun GmbH
Status:
PATENT GRANTED
EP14831578

PROCESS FOR PRODUCING WATER-ABSORBING RESIN PARTICLE

IPC classification:
C08F 2/32, C08F 20/00, C08K 5/10, C08L 101/14
Applicant:
Sumitomo Seika Chemicals Co., Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP11716396

CHITOSAN COMPOSITION

IPC classification:
C08L 5/08, A61K 9/06, A61K 31/337, A61K 31/4439, A61K 31/58, A61K 31/593, A61K 47/36
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13176697

Method for forming semipermeable membranes for sensor applications using photopolymerizable silicone materials

IPC classification:
G01N 27/40, G01N 33/543, G03F 7/075
Applicant:
Dow Corning Corporation
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196726

AN INHALER COMPRISING A TIOTROPIUM-CONTAINING-COMPOSITION

IPC classification:
A61P 11/08, A61K 9/00, A61K 9/12, A61K 31/46, A61K 47/10, A61K 47/12, A61M 11/04, A61M 15/00
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP13152263

Hydrophilized substrate and method for hydrophilizing a hydrophobic surface of a substrate

IPC classification:
B32B 9/04, B32B 27/30, C08G 65/335, C08J 7/04, D06M 13/288, D06M 15/333, D06M 15/53, D06M 15/667, D21H 17/10, D21H 27/30
Applicant:
Solvay USA Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
PATENT GRANTED
EP11796916

INHALERS WITH HOUSING CAPS FOR INHALERS

IPC classification:
A61M 15/00
Applicant:
Teva Pharmaceutical Industries Ltd.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Agent:
David William Cottam, Teva UK Ltd.
Status:
PATENT GRANTED
EP15732545

AEROSOL DEVICE

IPC classification:
A61M 15/00, A61M 15/08
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP16185402

AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM

IPC classification:
A61P 11/00, A61K 9/00, A61K 9/12, A61K 31/46, A61K 47/10, A61K 47/12, A61M 15/00
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP15784372

PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN

IPC classification:
C07D 413/14
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP15874145

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

IPC classification:
A61P 31/18, A61P 35/00, C07H 19/067, A61K 31/7068
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made
EP16705611

AN INHALABLE MEDICAMENT

IPC classification:
A61K 9/72, A61K 31/573
Applicant:
Teva Branded Pharmaceutical Products R & D, Inc.
Agent:
Richard Edward Gillard, Elkington and Fife LLP
Status:
Request for examination was made

Please Sign in to use this feature